AbCellera reports favourable Phase II data for ABCL635
The study achieved primary efficacy endpoints, showing significant reductions in frequency and severity at week four.
11 August 2026
11 August 2026
The study achieved primary efficacy endpoints, showing significant reductions in frequency and severity at week four.
Acarix will launch the CADScor system in the UAE through UniTech Solutions, which will manage regional distribution.
As part of the deal, Actio Biosciences will spin out a new company focused on genetic rare neurological diseases.
The procedure was carried out at the CARTI Cancer Center Little Rock, Arkansas, US.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.